The China precision medicine market is booming, projected to reach $6.2 billion in 2025 and grow at a CAGR of 12.7% through 2033. This report analyzes market drivers, trends, restraints, key players (Roche, AstraZeneca, Sansure Biotech), and segments (Oncology, Genomics, Bioinformatics). Discover the opportunities in this rapidly expanding sector.

Our Clients

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.